相关实验视频

Updated: May 1, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

揭示神经性生物标志物,以区分有或没有脑病变的败血症患者:更新的元分析

Jiyun Hu¹, Wenchao Li¹, Shucai Xie¹

¹Department of Critical Care Medicine, Hunan Provincial Clinical Research Center for Critical Care Medicine, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

Systematic reviews

|February 8, 2025

概括

血清神经原生物标志物在败血症相关脑病变 (SAE) 中升高,可以预测死亡率. 这些生物标志物显示出对患者SAE的诊断和监测有前途.

科学领域:

神经科学是一个神经科学.
生物标志物生物标志物
关键护理医学关键护理医学

背景情况:

败血症相关脑病变 (SAE) 导致大脑功能障碍,认知障碍和死亡率增加.
准确的SAE诊断对于及时治疗和患者管理至关重要.
血清中的神经性生物标志物显示出SAE诊断和监测的潜力.

研究的目的:

评估SAE患者血清神经原生生物标志物的诊断和预后效用.
评估神经元特异性酶 (NSE),UCH-L1,Tau,S100β和GFAP的SAE诊断和死亡风险.

主要方法:

根据PRISMA指南,对42项研究进行了元分析.
在主要数据库 (PubMed,科学网,Embase等) 进行系统的文献搜索. ) 的情况.
用于质量评估的QUADAS-2工具;由于异质性而应用随机效应模型.

主要成果:

在SAE患者中,血清NSE,UCH-L1,Tau,S100β和GFAP水平明显高于没有脑病变的患者.
与非幸存者相比,在幸存者中观察到较低的NSE,UCH-L1,Tau和S100β血清水平.
在幸存者和非幸存者组之间没有发现血清GFAP水平的显著差异.

结论:

血清神经原生生物标志物升高可能预测出血病患者的SAE和死亡率.
这些生物标志物可以作为可靠的基于血液的工具来检测和监测SAE.
高异质性要求对结果进行谨慎的解释.

关键词:

生物标志物生物标志物在GFAPAP中,GFAP是最重要的.在 NSE NSE 里面.在S100ββ中,它是S100ββ.败血症相关的脑病变 - - 败血症相关的脑病变塔乌·塔乌 (Tau Tau) 是一个在UCH-1中使用.

更多相关视频

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

相关概念视频

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Cerebral Edema ll: Pathophysiology

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...